Pancreatic calcification is a characteristic feature of chronic pancreatitis, representing long-standing inflammation and irreversible structural damage to the pancreatic parenchyma. It is commonly associated with alcohol abuse, metabolic abnormalities, or idiopathic etiologies. Patients typically present with chronic abdominal pain, malabsorption, steatorrhea, and endocrine dysfunction such as diabetes mellitus. Radiological imaging, particularly contrast-enhanced computed tomography (CT), plays a pivotal role in diagnosis by demonstrating intraductal and parenchymal calcifications.
This case report describes a 45-year-old male presenting with recurrent abdominal pain and weight loss, ultimately diagnosed with chronic calcific pancreatitis. The report emphasizes the diagnostic approach, therapeutic management, and favorable clinical outcome following timely intervention and lifestyle modification.
Pancreatic calcification is most frequently seen in the setting of chronic pancreatitis, a progressive inflammatory disease characterized by fibrosis, ductal distortion, and eventual loss of both exocrine and endocrine pancreatic function. The formation of calcifications results from precipitation of calcium salts within proteinaceous plugs in the pancreatic ducts, leading to obstruction and further glandular damage.
The global burden of chronic pancreatitis is significant, particularly in regions with high alcohol consumption and tropical pancreatitis prevalence. The disease is associated with substantial morbidity, including chronic pain syndromes, malnutrition, and diabetes.
Risk factors include chronic alcohol intake, smoking, genetic mutations, autoimmune processes, and metabolic disturbances such as hypercalcemia and hypertriglyceridemia. Early recognition and appropriate management are crucial to prevent complications and improve patient outcomes.
Patient History
A 45-year-old male presented to the gastroenterology outpatient department with complaints of recurrent upper abdominal pain for the past 8 months.

The pain was dull, aching, and localized to the epigastric region, with radiation to the back. It was aggravated after meals and partially relieved by leaning forward.

The patient also reported:
Progressive weight loss (~7 kg over 6 months)
Decreased appetite
Intermittent nausea
Passage of bulky, foul-smelling, oily stools suggestive of steatorrhea
There was a significant history of chronic alcohol consumption (approximately 60–80 g/day) for over 15 years. There was no history of gallstone disease, prior abdominal surgery, or known metabolic disorders.
On examination:
Mild epigastric tenderness was noted
No palpable mass or organomegaly
No icterus or lymphadenopathy
Vital parameters were stable, and systemic examination was unremarkable.
Differential Diagnosis
Based on clinical presentation, the following conditions were considered:
Chronic pancreatitis
Pancreatic carcinoma
Peptic ulcer disease
Gallstone-related pancreatitis
Functional dyspepsia
The chronicity of symptoms, steatorrhea, and alcohol history strongly suggested chronic pancreatitis.
Laboratory Findings
Serum amylase and lipase: Mildly elevated
Fasting blood glucose: Elevated (indicative of impaired glucose metabolism)
Liver function tests: Within normal limits
Serum calcium and triglycerides: Normal
Imaging Studies
Ultrasound Abdomen:
Irregular, heterogeneous pancreatic echotexture
Multiple echogenic foci with acoustic shadowing

Contrast-Enhanced CT Scan (CECT):
Multiple calcifications within the pancreatic duct and parenchyma
Dilatation of the main pancreatic duct
Pancreatic atrophy
These findings were diagnostic of chronic calcific pancreatitis.
Based on clinical presentation and radiological confirmation, the diagnosis was established as:
Chronic calcific pancreatitis with exocrine and early endocrine insufficiency secondary to chronic alcohol use
Initial Management
The patient was managed conservatively with a multidisciplinary approach involving gastroenterologists, dieticians, and endocrinologists.

Pharmacological Treatment
Pancreatic enzyme replacement therapy (PERT) to improve digestion
Analgesics following a stepwise approach for pain control
Proton pump inhibitors to enhance enzyme efficacy
Insulin therapy for glycemic control
Lifestyle and Dietary Modifications
Strict abstinence from alcohol
Low-fat, high-protein diet
Small, frequent meals
Supportive Measures
Nutritional supplementation
Fat-soluble vitamins (A, D, E, K)
Patient education regarding disease progression
Follow-Up
At 2 weeks:
Marked reduction in abdominal pain
Improved appetite
At 1 month:
Decrease in steatorrhea
Weight stabilization
At 3 months:
Significant symptomatic improvement
Better glycemic control
Improved quality of life
Outcome
The patient demonstrated:
Effective pain relief
Improved nutritional status
Stabilization of pancreatic function
No recurrence of acute exacerbations
Pancreatic calcification is a hallmark of advanced chronic pancreatitis and signifies long-standing, irreversible damage to the pancreatic parenchyma, often reflecting the end stage of a progressive inflammatory process. It is associated with repeated episodes of pancreatic injury, leading to structural remodeling, fibrosis, and loss of both exocrine and endocrine function over time.
The pathogenesis involves the formation of intraductal protein plugs due to altered pancreatic secretions, particularly decreased bicarbonate and increased protein concentration. These plugs act as a nidus for calcium salt deposition, eventually resulting in calcified stones within the pancreatic ducts and parenchyma. Progressive calcification leads to ductal obstruction, increased intraductal pressure, and further parenchymal damage, perpetuating a cycle of inflammation and fibrosis that contributes to glandular atrophy and functional impairment.
Etiology and Risk Factors
Common causes include:
Chronic alcohol consumption
Idiopathic pancreatitis
Tropical pancreatitis
Genetic mutations (PRSS1, SPINK1)
Metabolic abnormalities
Patients typically present with:
Chronic epigastric pain radiating to the back
Weight loss
Steatorrhea
Diabetes mellitus
Diagnostic Approach
Detailed clinical history
Laboratory investigations
Imaging (CT scan as gold standard)
Endoscopic evaluation (if indicated)
CT imaging remains the most sensitive modality for detecting pancreatic calcifications.
1. Medical Management
Pain control
Enzyme supplementation
Glycemic management
2. Lifestyle Modification
Alcohol cessation
Dietary regulation
3. Interventional Management
Endoscopic therapy for ductal stones
Surgical decompression in refractory cases
If untreated, chronic pancreatitis with calcification may lead to:
Pancreatic pseudocysts
Diabetes mellitus
Severe malnutrition
Pancreatic malignancy
The prognosis depends on disease severity, adherence to treatment, and lifestyle modification. Early intervention and alcohol abstinence significantly improve outcomes, although structural damage is largely irreversible.
Pancreatic calcification is a critical indicator of chronic pancreatitis and signifies advanced disease with irreversible pancreatic damage. This case highlights the importance of early clinical suspicion in patients with chronic abdominal pain and relevant risk factors such as long-term alcohol use.
A systematic diagnostic approach, particularly the use of CT imaging, enables accurate identification of calcifications and disease severity. Timely initiation of enzyme replacement therapy, adequate pain management, and strict lifestyle modifications are essential in improving patient outcomes and preventing complications.
Preventive strategies, including alcohol cessation and nutritional optimization, play a pivotal role in disease control. With appropriate management and follow-up, patients can achieve significant symptomatic relief and improved quality of life despite the chronic nature of the disease.
Whitcomb DC. Chronic pancreatitis: an update on pathogenesis and management. https://pubmed.ncbi.nlm.nih.gov/
Yadav D, Lowenfels AB. Epidemiology of pancreatitis and pancreatic cancer. https://pubmed.ncbi.nlm.nih.gov/
Stevens T, Conwell DL. Chronic pancreatitis: diagnosis and management. https://pubmed.ncbi.nlm.nih.gov/
Drewes AM, et al. Pain management in chronic pancreatitis. https://pubmed.ncbi.nlm.nih.gov/
Braganza JM, et al. Chronic pancreatitis and calcification mechanisms. https://pubmed.ncbi.nlm.nih.gov/
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
2.
According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.
3.
COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment
4.
It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.
5.
Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.
1.
Cracking Oncology Drug Resistance: New Strategies to Overcome Challenges in Modern Cancer Therapy
2.
Case Study: Genomic Medicine in Precision Oncology
3.
Understanding Mean Corpuscular Volume: A Comprehensive Guide
4.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
5.
Advancing Medical Oncology: Education, Certification, Clinical Trials, and Evolving Treatment Pathways
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation